Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 25;12:7869–7884. doi: 10.2147/IJN.S143977

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Hua et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

In vivo evaluation of the antitumor efficacy of the listed treatments.

Notes: (A) Tumor volume data during 15 days of treatment with the listed formulations. (B) Tumor weight and calculated tumor inhibition rate after 15 days of treatment with the listed formulations. (C) Tumor images after 15 days of treatment with the listed formulations (1–6: saline; Doc solution; GNRs/DocL; GNRs/DocL + laser; GNRs/DocL-R; GNRs/DocL-R + laser, respectively). (D) Body weight data during 15 days of treatment with the listed formulations. Data are presented as mean ± SD (N=5). ⁺GNRs/DocL-R vs GNRs/DocL-R + laser, p<0.05. *GNRs/DocL + laser vs GNRs/DocL-R + laser, p<0.01. ^#GNRs/DocL vs GNRs/DocL + laser, p<0.05.

Abbreviations: Doc, docetaxel; GNRs, gold nanorods; GNRs/DocL-R, GNRs/Doc-liposome-RLT.